Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression
International Journal of Medical Sciences Sep 29, 2017
Su CW, et al. - This study was performed to investigate the role of plasma tissue inhibitor of metalloproteinase-3 (TIMP3) levels in oral squamous cell carcinoma (OSCC) progression. For predicting the tumor stage and T status, plasma TIMP3 was a potential biomarker in patients with OSCC.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
